annual cash & cash equivalents:
$929.03M+$452.02M(+94.76%)Summary
- As of today (May 20, 2025), RPRX annual cash & cash equivalents is $929.03 million, with the most recent change of +$452.02 million (+94.76%) on December 31, 2024.
- During the last 3 years, RPRX annual cash & cash equivalents has fallen by -$612.02 million (-39.71%).
- RPRX annual cash & cash equivalents is now -51.72% below its all-time high of $1.92 billion, reached on December 31, 2018.
Performance
RPRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.09B+$158.69M(+17.08%)Summary
- As of today (May 20, 2025), RPRX quarterly cash & cash equivalents is $1.09 billion, with the most recent change of +$158.69 million (+17.08%) on March 31, 2025.
- Over the past year, RPRX quarterly cash & cash equivalents has increased by +$244.72 million (+29.03%).
- RPRX quarterly cash & cash equivalents is now -55.48% below its all-time high of $2.44 billion, reached on June 30, 2020.
Performance
RPRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RPRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.8% | +29.0% |
| 3 y3 years | -39.7% | -39.3% |
| 5 y5 years | +277.4% | +74.2% |
RPRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.7% | +94.8% | -50.0% | +128.0% |
| 5 y | 5-year | -45.7% | +277.4% | -55.5% | +128.0% |
| alltime | all time | -51.7% | +277.4% | -55.5% | +341.8% |
RPRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.09B(+17.1%) |
| Dec 2024 | $929.03M(+94.8%) | $929.03M(-2.2%) |
| Sep 2024 | - | $950.05M(-46.2%) |
| Jun 2024 | - | $1.76B(+109.3%) |
| Mar 2024 | - | $843.00M(+76.7%) |
| Dec 2023 | $477.01M(-72.1%) | $477.01M(-49.1%) |
| Sep 2023 | - | $936.45M(-56.9%) |
| Jun 2023 | - | $2.17B(+10.0%) |
| Mar 2023 | - | $1.98B(+15.5%) |
| Dec 2022 | $1.71B | $1.71B(+72.5%) |
| Sep 2022 | - | $991.63M(-53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.11B(+17.7%) |
| Mar 2022 | - | $1.79B(+16.3%) |
| Dec 2021 | $1.54B(+52.8%) | $1.54B(-14.4%) |
| Sep 2021 | - | $1.80B(+57.7%) |
| Jun 2021 | - | $1.14B(+61.2%) |
| Mar 2021 | - | $708.81M(-29.7%) |
| Dec 2020 | $1.01B(+309.7%) | $1.01B(-35.0%) |
| Sep 2020 | - | $1.55B(-36.4%) |
| Jun 2020 | - | $2.44B(+291.3%) |
| Mar 2020 | - | $624.37M(+153.6%) |
| Dec 2019 | $246.20M(-87.2%) | $246.20M |
| Dec 2018 | $1.92B | - |
FAQ
- What is Royalty Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Royalty Pharma?
- What is Royalty Pharma annual cash & cash equivalents year-on-year change?
- What is Royalty Pharma quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Royalty Pharma?
- What is Royalty Pharma quarterly cash & cash equivalents year-on-year change?
What is Royalty Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of RPRX is $929.03M
What is the all time high annual cash & cash equivalents for Royalty Pharma?
Royalty Pharma all-time high annual cash & cash equivalents is $1.92B
What is Royalty Pharma annual cash & cash equivalents year-on-year change?
Over the past year, RPRX annual cash & cash equivalents has changed by +$452.02M (+94.76%)
What is Royalty Pharma quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RPRX is $1.09B
What is the all time high quarterly cash & cash equivalents for Royalty Pharma?
Royalty Pharma all-time high quarterly cash & cash equivalents is $2.44B
What is Royalty Pharma quarterly cash & cash equivalents year-on-year change?
Over the past year, RPRX quarterly cash & cash equivalents has changed by +$244.72M (+29.03%)